These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9003536)

  • 1. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques.
    Nishino H; Buettner VL; Sommer SS
    Mutat Res; 1996 Nov; 372(1):97-105. PubMed ID: 9003536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA; Buettner VL; Glickman BW; Sommer SS
    Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
    Watson DE; Cunningham ML; Tindall KR
    Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy.
    Gu M; Ahmed A; Wei C; Gorelick N; Glickman BW
    Mutat Res; 1994 Jun; 307(2):533-40. PubMed ID: 7514727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
    Young RR; Rogers BJ; Provost GS; Short JM; Putman DL
    Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays.
    Morrison V; Ashby J
    Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
    Bielas JH
    Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous mutation in lacI transgenic mice: a comparison of tissues.
    de Boer JG; Provost S; Gorelick N; Tindall K; Glickman BW
    Mutagenesis; 1998 Mar; 13(2):109-14. PubMed ID: 9568581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous microdeletions and microinsertions in a transgenic mouse mutation detection system: analysis of age, tissue, and sequence specificity.
    Halangoda A; Still JG; Hill KA; Sommer SS
    Environ Mol Mutagen; 2001; 37(4):311-23. PubMed ID: 11424181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
    Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line.
    Zimmer DM; Zhang XB; Harbach PR; Mayo JK; Aaron CS
    Environ Mol Mutagen; 1996; 28(4):325-33. PubMed ID: 8991060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel germline mutation in Big Blue mice.
    Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
    Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
    Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
    Shane BS; deBoer JG; Glickman BW; Cunningham ML
    Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
    Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
    Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice.
    Skopek T; Marino D; Kort K; Miller J; Trumbauer M; Gopal S; Chen H
    Mutat Res; 1998 May; 400(1-2):77-88. PubMed ID: 9685590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.